In the present study, consistent with ES dependence on EZH2 as a consequence of INI1 deficiency [16], we observed significant antitumor activity of EPZ-011989 in our PDX model, although with different kinetics of tumor growth inhibition compared to chemotherapeutics. This evidence concerns the gene SMARCB1 and neoplasm.